The Quantellect read.As of Nov 19, 2026, 3 active firms cover Amdocs Ltd: 2 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $71.00 to $92.00, so the covering firms are broadly aligned. The average target of $81.50 sits 93% above the current $42.30. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.34 next quarter toward $6.12 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy267%
Neutral133%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$81.50
+92.7% upside
Average target across 2 active firms as of Nov 19, 2026 vs $42.30 current
Highest Target$92.00
Average Target$81.50
Lowest Target$71.00
Detailed analyst forecasts for DOX
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 2 of 3 active firms rate DOX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
DOX EPS & revenue forecast
EPS · NEXT QUARTER
$1.34
Range $1.28 – $1.44 · 5 analysts · -25% YoY
Next period, 5 analysts expect Amdocs Ltd to earn $1.34 a share (range $1.28 – $1.44), versus $1.78 a year earlier. Full-year consensus is $5.38, growing to $6.12 the year after.
REVENUE · NEXT QUARTER
$979.6M
Range $971.7M – $984.5M · 5 analysts · -16% YoY
Revenue is expected to reach $979.6M (range $971.7M – $984.5M), -16.4% year-over-year. Full-year consensus is $3.9B, rising to $4.1B next year.
Top analysts covering Amdocs Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DOX.
#1
Timothy Horan
Oppenheimer · Rank #310
Buy
$105.00+148.2% to target
Overall win rate
36%
+ Follow
#2
Shlomo Rosenbaum
Stifel · Rank #486
Buy
$71.00+67.8% to target
Overall win rate
25%
+ Follow
#3
GN
George Notter
Wolfe Research
Neutral
No targeton DOX
Coverage
—
+ Follow
#4
TR
Tavy Rosner
Barclays
Buy
$92.00+117.5% to target
Coverage
—
+ Follow
#5
DA
Devin Au
Keybanc
Neutral
No targeton DOX
Coverage
—
+ Follow
DOX stock forecast FAQ
What is DOX's average 12-month price target?+
The 2 active firms with a live target average $81.50 for Amdocs Ltd over the next 12 months, ranging from a $92.00 high to a $71.00 low, as of Nov 19, 2026.
Is DOX stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for DOX?+
The Street-high target is $92.00 (Barclays), and the Street-low is $71.00 (Stifel). The average of all 2 active-firm targets is $81.50.
How many active Wall Street firms cover DOX?+
3 active firms have a recognized rating on Amdocs Ltd as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering DOX?+
Among analysts who currently cover DOX, Timothy Horan of Oppenheimer has the strongest overall Quantellect track record (Rank #310). Their current call is Buy with a $105.00 target.
What is Amdocs Ltd's projected EPS for next quarter?+
The consensus estimate is $1.34 per share (range $1.28 – $1.44) across 5 analysts. Full-year EPS is projected at $5.38, rising to $6.12 the following year.
How much revenue is Amdocs Ltd expected to report next quarter?+
Consensus revenue is $979.6M (range $971.7M – $984.5M). Full-year revenue is projected at $3.9B, growing to $4.1B next year.
Have analysts been upgrading or downgrading DOX lately?+
As of Nov 19, 2026, 2 of 3 active firms rate DOX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DOX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.